Detalhe da pesquisa
1.
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.
Future Oncol
; 19(1): 61-75, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36656302
2.
APOBEC-mediated DNA alterations: A possible new mechanism of carcinogenesis in EBV-positive gastric cancer.
Int J Cancer
; 146(1): 181-191, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31090066
3.
The diffuse-type gastric cancer epidemiology enigma.
BMC Gastroenterol
; 20(1): 223, 2020 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32660428
4.
Identification of DNA mutations in gastric washes from gastric adenocarcinoma patients: Possible implications for liquid biopsies and patient follow-up.
Int J Cancer
; 145(4): 1090-1098, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30779121
5.
Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities.
Oncologist
; 24(8): e709-e719, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30910864
6.
ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer.
Future Oncol
; 15(26): 3003-3014, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31339357
7.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Target Oncol
; 18(3): 425-440, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37017806
8.
Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma.
Cell Oncol (Dordr)
; 45(3): 479-504, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35567709
9.
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Clin Lung Cancer
; 23(6): 522-531, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35798634
10.
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Lung Cancer
; 170: 114-121, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35753125
11.
Concordance Analysis of ALK Gene Fusion Detection Methods in Patients with Non-Small-Cell Lung Cancer from Chile, Brazil, and Peru.
J Mol Diagn
; 23(9): 1127-1137, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34186175
12.
Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention.
Cancers (Basel)
; 13(3)2021 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33513945
13.
Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus).
Thorac Cancer
; 12(9): 1328-1335, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33729676
14.
Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.
Front Oncol
; 10: 1068, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32714871
15.
Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 21(6): e511-e515, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32389509
16.
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.
Crit Rev Oncol Hematol
; 153: 103033, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32650215
17.
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP).
Front Oncol
; 9: 254, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31058075
18.
Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP).
Thorac Cancer
; 10(3): 508-518, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30706690
19.
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).
Lung Cancer
; 125: 265-272, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30429031
20.
Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With METamp After Osimertinib First-Line Treatment.
JCO Precis Oncol
; 6: e2200367, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36201715